In New Zealand, can a patient be eligible for empagliflozin and GLP-1 RA?
Tripdatabase;
In New Zealand, can a patient be eligible for empagliflozin and GLP-1 RA?
Patients in New Zealand may be eligible for empagliflozin and GLP-1 RAs depending on individual risk profiles and specific criteria for accessing funded therapies, mainly prioritizing those with cardiovascular or renal risks.
endocrinology, diabetes, treatment, empagliflozin, GLP-1 RA, pharmacology, eligibility, New Zealand
endocrinology, diabetes, treatment, empagliflozin, GLP-1 RA, pharmacology, eligibility, New Zealand
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
selected citations
Citations provided by BIP!
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
Citations provided by BIP!popularityPopularity provided by BIP!
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
Popularity provided by BIP! 0
Average
Average
Average